venBio Partners’s Attovia Therapeutics ATTO Stock Holding History
Bought
Maintained
Sold
Other funds holding ATTO
venBio Partners's ATTO Position: Q3 2026 in Review
venBio Partners opened a new position in Attovia Therapeutics (ATTO) in Q3 2026: 4,181,366 shares worth $71.7M. The stake represents 14.45% of the portfolio and ranks #3 among its holdings.
57 funds tracked by Wall St. Rank hold ATTO as of Q3 2026.
- venBio Partners held 4,181,366 shares of Attovia Therapeutics worth $71.7M as of Q3 2026.
- Attovia Therapeutics was a new venBio Partners position in Q3 2026.
- Attovia Therapeutics made up 14.45% of venBio Partners's portfolio in Q3 2026, its #3 holding.
- 57 funds tracked by Wall St. Rank held Attovia Therapeutics as of Q3 2026.
Based on venBio Partners's 13F filing for Q3 2026, filed 16 Nov 2026.